What’s best: jumping in or staying out? Sangamo Therapeutics Inc (SGMO) Stock
RBC Capital Mkts lowered the price target for the Sangamo Therapeutics Inc (NASDAQ:SGMO) stock from “an Outperform” to “a Sector perform”. The rating was released on November 03, 2023, according to finviz. We previously noted in another research note published on April 28, 2023 by BofA Securities that downgraded the stock from a Neutral to […]
Sangamo Therapeutics Inc (SGMO) Stock at a key inflection point
RBC Capital Mkts lowered the price target for the Sangamo Therapeutics Inc (NASDAQ:SGMO) stock from “an Outperform” to “a Sector perform”. The rating was released on November 03, 2023, according to finviz. We previously noted in another research note published on April 28, 2023 by BofA Securities that downgraded the stock from a Neutral to […]
Getting Ready for the Bounce: Sangamo Therapeutics Inc (SGMO) Stock
RBC Capital Mkts lowered the price target for the Sangamo Therapeutics Inc (NASDAQ:SGMO) stock from “an Outperform” to “a Sector perform”. The rating was released on November 03, 2023, according to finviz. We previously noted in another research note published on April 28, 2023 by BofA Securities that downgraded the stock from a Neutral to […]
Sangamo Therapeutics Inc (SGMO) Stock to return to profitability in the near future
RBC Capital Mkts lowered the price target for the Sangamo Therapeutics Inc (NASDAQ:SGMO) stock from “an Outperform” to “a Sector perform”. The rating was released on November 03, 2023, according to finviz. We previously noted in another research note published on April 28, 2023 by BofA Securities that downgraded the stock from a Neutral to […]
Is Sangamo Therapeutics Inc (SGMO) Stock Paving the Way for Earnings?
RBC Capital Mkts lowered the price target for the Sangamo Therapeutics Inc (NASDAQ:SGMO) stock from “an Outperform” to “a Sector perform”. The rating was released on November 03, 2023, according to finviz. We previously noted in another research note published on April 28, 2023 by BofA Securities that downgraded the stock from a Neutral to […]
If you still want to check out Sangamo Therapeutics Inc (SGMO) Stock, you should do so again
RBC Capital Mkts lowered the price target for the Sangamo Therapeutics Inc (NASDAQ:SGMO) stock from “an Outperform” to “a Sector perform”. The rating was released on November 03, 2023, according to finviz. We previously noted in another research note published on April 28, 2023 by BofA Securities that downgraded the stock from a Neutral to […]
Sangamo Therapeutics Inc (SGMO) Stock is poised for a successful quarter
RBC Capital Mkts lowered the price target for the Sangamo Therapeutics Inc (NASDAQ:SGMO) stock from “an Outperform” to “a Sector perform”. The rating was released on November 03, 2023, according to finviz. We previously noted in another research note published on April 28, 2023 by BofA Securities that downgraded the stock from a Neutral to […]
